Chinese telecoms giant Huawei says it will continue to invest in the United States despite recent setbacks in its efforts to boost sales.
"We are keen to collaborate with other nations that are engaged in this endeavour, so we are a leader not a follower in assessment of 5G technology," he said.
The Department of Telecom has started harmonising spectrum in 3,500 megahertz band and 26 Gigahertz band along with E and V band, she said.
Ericsson unveiled at MWC a report that lays out a roadmap for operators to unlock the revenue potential of 5G-enabled industry digitalisation.
BSNL and Japan's NTT AT along with their Indian partner Virgo Corps have signed agreement to collaborate in futuristic technologies.
"By June this year, I hope we will be able to unveil India's 5G roadmap," Telecom Secretary Aruna Sundararajan said.
Mobile technology major Ericsson demonstrated the new technology, delivering a speed of 5.7 gigabytes per second.
Ericsson said it has partnered with Bharti Airtel for 5G technology for the telecom giant's India operations.
Nokia will trial its 5G technology in South Africa in collaboration with Vodacom Group, the firms said as they seek to provide faster data delivery.
Ericsson said it is in advance talks with some leading telecom operators in India over 5G technology and expect to sign MoU with them within 6 months.
Blackstone to buy 80% in Pune mall for Rs 310 Cr
Blackstone Group is set to buy an 80% majority stake in Nitesh Hub
Remaining stake in the mall will remain with Nitesh Estates
Eyes palm oil business and may join race to acquire Ruchi Soya
Godrej Agrovet is yet to formally approach Ruchi Soya on the same
ITC , Patanjali Ayurved and Emami are other cos which have shown interest
SC upholds sale of hotel property of Blue Coast Hotels by co
Earlier, Bombay HC had set aside the sale
SC sets aside Bombay HC ruling
SC allows IFCI to retain sale proceeds of Rs 515.4 cr
Gets USFDA nod for ANDA for Metformin Extended Release tablets
Gets approvals for drugs of strength 500 mg, 750 mg
Approved ANDA bioequivalent of Glucophage XR of Bristol Myers Squibb
Co eyes to commercialise product soon
Gets Shareholders' Nod for sale of equity shares of unit Hypercity Retail
FPI limit under Portfolio Investment Scheme increased from 24% to 49%